3rd Lab Asset and Facility Management in Pharma

Memo

Whether you are looking for ways to support the growth of your company, regain control of your assets and inventory spend or discover the latest lab digitalization solutions the 3rd Lab Asset and Facility Management in Pharma has the industry insight for you. With exciting content across 2 parallel tracks, this meeting offers more dedicated conversations and case studies for asset and facility leaders than ever before. Stay current with Lab Asset and Facility Management in Pharma:Hear from your industry peers' case studies as well as solution providers customer examples to enhance your lab operations, particularly during covid-19 lab reorganisation. Engage and immerse in a truly interactive virtual meeting:Pose your questions to expert speakers and panellists in our live Q and A and roundtables, just as you would at a physical conference. Connect with industry thought leaders and showcase your thought leadership:Do not be deterred by social distancing - showcase your unique service and products in our virtual exhibition halls and we will help you with 121 meetings. Unparalleled content access:Imagine never missing a talk - all approved presentations will be distributed to participants post-event for a month, with additional on-demand video recordings for download. The 3rd Lab Asset and Facility Management in Pharma will return this Winter as your ONLY industry led meeting focusing on R and D asset and FM, enabling you to regain control of your assets, optimize your space and benchmark best practices to stay ahead of the curve. Through strategic planning and rolling out digital tracking, Lab Asset, Operations and FM Directors are beginning to regain control of their inventory, asset value and optimize facility footprint to: Reduce unnecessary downtime and ensure reliable business operationsStrengthen relationships and drive innovative partnership models with OEMsMaximize asset lifecycle and value - and make informed financial decisions during purchasing, renewing, reselling and auctioningOptimize lab and working space. Implementing the ethos of shared economy within the R and D scientific communityEnhance capital efficiency to re-invest in drug development programs This event is FREE to attend for biotech, pharma and academics. URLs:Tickets: https://go.evvnt.com/666237-1?pid=5569Brochure: https://go.evvnt.com/666237-3?pid=5569 Date and Time: On Tuesday November 10, 2020 at 9:00 am ends Thursday November 12, 2020 at 3:00 pm Price:Free Industry Passes: USD 0.00 Speakers: James Mauro, Director - Global Lab Asset Management Program, Merck, Adam Schnirel, Associate Director Operations, UCSF, Demet Aybar, Associate Director of Lab Operations, Scholar Rock, Adolfo Scherch, Utilities and Technical Services Coordinator, Novartis, Dean Naylor, Laboratory Equipment Manager, Quest Diagnostics, Stephen Powell, Laboratory Capital Equipment Lead, Bristol-Myers Squibb, Kelly Edge, Krupa Lab Asset Service Manager, Integrated Laboratory Strategy and Operations, Bristol-Myers Squibb, Gregg York, Facilities Operations, Translate Bio, Annie Kang, Associate Director of Research Operations, Cue BioPharma, Andrew Sargent, Director, IT, R and D Systems, Arvinas, Kevin Walsh, Senior Lab Manager, Guardian Therapeutics, Steven Planchon, Asset Lifecycle Manager, Pfizer, Jedd Skibo, Director Global Category Procurement, Charles River Labs, Jennifer Keller, Director, Strategy and Planning, Johnson and Johnson, Nicole Visaggio, Specialist, Lab Operations, BlueRock Therapeutics, Marie Pisello, Senior Manager, Space and Workplace, Foundation Medicine, Kimberly Dougherty, Associate Director, Laboratory Operations, Vertex, Mark Narcy, Senior Facilities and Operations Manager, Crinetics, Jessie Dow, Lab Operations Lead, Pfizer, Susan Belzer, Strategic Laboratory Director, ALVA10, Bill VanDeWeghe, President and Chief Executive Officer, BioSurplus Inc, Nick Dove, Executive Vice President, Heritage Global Partners, Inc, Diana Hage, Chief Executive Officer, RFID Global Solution, Inc, John Rey, Senior Vice President, Able Services, Priya Vijayakumar, President and Chief Operating Officer, WattIQ, David Heiger, Associate Vice President - Marketing, Agilent Technologies, Kent Koeman, Vice President - Sales and Marketing, TTE Laboratories/ Pipettes.com, Paul Watts ,Group Operations Director, iLS EMEA, CBRE, Scott Prier, Director of Service, PHC Corporation of North America (PHCNA), Jim Sweeney, Sr. Product Manager, Technology Svc, PerkinElmer